Next Article in Journal
Trichomonacidal Activity of 3,3′-Diindolylmethane (DIM) Is Additive to Metronidazole (MTZ) In Vitro, Supporting Future Oral/Topical Use
Previous Article in Journal
Aryl Sulfonamides as a New Antitubercular Series: Discovery, Optimization and Target Identification
Article Menu
Issue 6 (MMCS 2017) cover image

Article Versions

Export Article

Open AccessAbstract
Proceedings 2017, 1(6), 674;

Nitrosyl [2Fe-2S] Ferredoxin Mimetics as New Nitric Oxide Donating Antibacterial Agents

Institute of Problems of Chemical Physics Russian Academy of Sciences, 1, Acad. Semenov Av., 142432 Chernogolovka, Russia
Presented at the 1st Molecules Medicinal Chemistry Symposium, Barcelona, Spain, 8 September 2017.
Author to whom correspondence should be addressed.
Published: 19 October 2017
(This article belongs to the Proceedings of the 1st Molecules Medicinal Chemistry Symposium)
PDF [164 KB, uploaded 19 October 2017]
Note: In lieu of an abstract, this is an excerpt from the first page.


Nitric oxide (NO) therapy is the newest approach to the treatment of socially important diseases all over the world. [...]
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Sanina, N.; Kozub, G.; Kondrat’eva, T.; Mumyatova, V.; Terent’ev, A. Nitrosyl [2Fe-2S] Ferredoxin Mimetics as New Nitric Oxide Donating Antibacterial Agents. Proceedings 2017, 1, 674.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Proceedings EISSN 2504-3900 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top